Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Sangamo Therapeutics (NQ: SGMO)
11.02 USD  -0.42 (-3.67%)
Official Closing Price  /  Updated: 5:46 PM EDT, Aug 23, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,091,400
Open 11.35
Bid (Size) 10.96 (100)
Ask (Size) 11.15 (1)
Prev. Close 11.44
Today's Range 10.96 - 11.65
52wk Range 6.260 - 19.25
Shares Outstanding 101,494,606
Dividend Yield N/A
Performance
YTD
-6.45%
-6.45%
1 Month
-7.78%
-7.78%
3 Month
+13.37%
+13.37%
6 Month
+24.80%
+24.80%
1 Year
-28.90%
-28.90%
Top News
More News
Sangamo Therapeutics Reports Second Quarter 2019 Financial Results
Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today reported second quarter 2019 financial results and recent business highlights. Read More
from Business Wire News Releases
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that CEO Sandy Macrae will present at the 2019 Wedbush PacGrow Healthcare Conference in New York City. The... Read More
from Business Wire News Releases
More News
Read More
Sangamo Therapeutics Appoints Gary H. Loeb as Executive Vice President and General Counsel
from Business Wire News Releases
Sangamo Therapeutics Announces Second Quarter 2019 Conference Call and Webcast
from Business Wire News Releases
Sangamo Announces Nature Biotechnology Publication of New Strategies for Optimizing the Specificity of Gene Editing Nucleases
from Business Wire News Releases
Stocks Showing Improving Market Leadership: Sangamo Therapeutics Earns 82 RS Rating
from Investor's Business Daily
Sangamo Therapeutics Hits 80-Plus Relative Strength Rating Benchmark
from Investor's Business Daily
Sangamo Biosciences Inc (SGMO) Q2 2019 Earnings Call Transcript
category SGMO , Market News
from Motley Fool
What You'll Want to Know About Sangamo Therapeutics' Q2 Results
category PFE , Market News , SGMO
from Motley Fool
A Look At Benzinga Pro's Most-Searched Tickers For July 9, 2019
category AAPL , SOLY , ALT , and 12 more.
from Benzinga
A Look At Benzinga Pro's Most-Searched Tickers For July 8, 2019
category OASM , Market News , TRNX , and 12 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
© Copyright FinancialContent Services, Inc.